Skip to main content
Clinical Trials/NCT02062736
NCT02062736
Completed
Not Applicable

Studio Osservazionale Per Valutare l'Adeguatezza Del Dosaggio Del Metadone, Nelle Terapie di Mantenimento, in Rapporto Agli Obbiettivi di Outcome, in Pazienti Tossicodipendenti da Eroina. (METODO)

L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.5 sites in 1 country500 target enrollmentFebruary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heroin Addiction
Sponsor
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Enrollment
500
Locations
5
Primary Endpoint
the efficacy of the methadone maintenance treatment in addicted heroin patients, evaluating the correlation among efficacy and adequate dosage in comparison to not adequate dosage.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of the study ( observational and prospective ) is to evaluate the efficacy and tolerability of the methadone maintenance treatment in patients addicted to heroin. The efficacy and tolerability are assessed by correlating to the adequacy of the dosage of methadone. The patients will be observed for two years.

Detailed Description

500 patients will be selected among all patients addicted to heroin according to DSM-IV_TR (Diagnostic and Statistical Manual of Mental Disorders IV_ text revision), in maintenance methadone treatment, observed in the involved sites. The investigators will use treatment schemes with methadon conform to clinical practice and according to SPC (Summary of Product Characteristics). The enrollment will be competitive. Patients that meet incl/excl and that sign the informed consent, will be observed for 2 years. Follow up visits will be performed according to routine procedures, for patients that belong regularly to site at 3/6/9/12/18/24 months post V1. During the visits, patients will be assessed by validated and used as clinical practice questionnaires . For the evaluations of tolerability and safety the laboratory tests and electrocardiograms routinely performed will be collected.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
March 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Both sexes
  • Over 18 years of age
  • Patients with a diagnosis of heroin addiction according to ICD-10 (International Classification of Diseases)
  • Patients who have undertaken a methadone maintenance treatment
  • Adhesion to observational study by signing informed consent.

Exclusion Criteria

  • Inability to follow the observation
  • Diagnosis of decompensated psychotic disorders

Outcomes

Primary Outcomes

the efficacy of the methadone maintenance treatment in addicted heroin patients, evaluating the correlation among efficacy and adequate dosage in comparison to not adequate dosage.

Time Frame: 2 years ( 7 visits for patient )

Secondary Outcomes

  • pharmacoeconomic condition correlated with the adequate dosage in comparison to not adequate dosage.(2 years ( 7 visits for patient ))
  • QT prolongation risk in patients addicted to heroin who have undertaken MMT(2 years ( evaluation at t0, t0 +6/12/18/24 months))
  • psychopathological status of observed patients in correlation with the adequate dosage in comparison to not adequate dosages(2 years ( 7 visits for patient ))

Study Sites (5)

Loading locations...

Similar Trials